You are here

  • Home
  • Archive
  • Volume 99, Issue suppl 2
  • 073 ATRIAL FIBRILLATION ABLATION UNDER THERAPEUTIC WARFARIN IS SAFE WITH IMPROVED PATIENTS' EXPERIENCE AND POTENTIALLY COST-SAVING COMPARED TO BRIDGING LOW MOLECULAR WEIGHT HEPARIN

Citation Tools

Article menu

Download PDFPDF

BCS Abstracts 2013
073 ATRIAL FIBRILLATION ABLATION UNDER THERAPEUTIC WARFARIN IS SAFE WITH IMPROVED PATIENTS' EXPERIENCE AND POTENTIALLY COST-SAVING COMPARED TO BRIDGING LOW MOLECULAR WEIGHT HEPARIN
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Looi KL, Heck PM, Agarwal S, et al
073 ATRIAL FIBRILLATION ABLATION UNDER THERAPEUTIC WARFARIN IS SAFE WITH IMPROVED PATIENTS' EXPERIENCE AND POTENTIALLY COST-SAVING COMPARED TO BRIDGING LOW MOLECULAR WEIGHT HEPARIN
Heart 2013;99:A47.